WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix , Inc. (Nasdaq:NURO) announced today that Quell ® is now available at Brookstone.com . "Brookstone is known for selling leading edge technology," said Shai N. Gozani, M.D., Ph.D., President and CEO of NeuroMetrix .
WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix , Inc. (Nasdaq: NURO) announced today that Quell ® will be included in a new digital health initiative in over 500 Target ® stores nationwide beginning in April. "We are delighted that Target will include Quell in their digital health program,"
WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix , Inc. (Nasdaq: NURO) announced today that Quell ® will be available, beginning in June 2016 , in approximately 1,000 chain drug stores as part of a retail test with the two largest US drug retailers. "Consumers have told us that they expect to see and
Waltham -based company expands availability into brick-and-mortar locations of leading domestic and home merchandise retailer WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq: NURO) today announced the availability of its flagship product, Quell ® , at select number of Bed Bath & Beyond
WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq: NURO) announced today that Quell ® will be available in over 450 Best Buy ® stores nationwide beginning in mid-February and is now available for purchase on BestBuy.com . "More and more consumers are proactively looking for technology to
WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix , Inc. (Nasdaq: NURO) announced today that a major upgrade to the Quell Wearable Pain Relief technology has started shipping to consumers and healthcare providers. The latest version of the company's over-the-counter, 100% drug free chronic pain relief
WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (the "Company") (Nasdaq: NURO), a medical device company focused on the treatment and management of the neurological complications of diabetes, today announced a national distribution agreement with DJO Global for the SENSUS™ Pain Management
WALTHAM, Mass --(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq: NURO) announced today that Premera Blue Cross , a leading health plan in the Pacific Northwest , will pilot the Quell ® Wearable Pain Relief device within their organization. Through this innovative collaboration, Premera will provide
NeuroMetrix Announces Diabetic Neuropathy Scientific Advisory Board WALTHAM, Mass., Mar 21, 2011 (BUSINESS WIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) announced today that it has formed a scientific advisory board of international experts to help guide the scientific, clinical and market development
NeuroMetrix Announces Distribution Agreement with OneSource Medical Group for SENSUS Pain Management Device WALTHAM, Mass. --(BUSINESS WIRE)--Nov. 1, 2012-- NeuroMetrix, Inc. (Nasdaq: NURO), a medical device company focused on the diagnosis and treatment of the neurological complications of
